HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCarter, R. J. Articles by Chalew, S. A. Search for Related Content PubMed PubMed Citation Articles by McCarter, R. J. Articles by Chalew, S. A. Social Bookmarking                What's this?

Mean Blood Glucose and Biological Variation Have Greater Influence on HbA_1c Levels Than Glucose Instability

An analysis of data from the Diabetes Control and Complications Trial

¹ Biostatistics and Informatics Unit, Children’s Research Institute of Children’s National Medical Center, Washington, DC
² Department of Pediatrics, Louisiana State University Heath Sciences Center, New Orleans, Louisiana
³ Department of Endocrinology/Diabetes, Children’s Hospital of New Orleans, New Orleans, Louisiana
⁴ Research Institute for Children, New Orleans, Louisiana

Address correspondence and reprint requests to Dr. Stuart Chalew, Department of Endocrinology/Diabetes, Children’s Hospital of New Orleans, 200 Henry Clay Ave., New Orleans, LA 70118. E-mail: schale{at}lsuhsc.edu

OBJECTIVE—Mean blood glucose (MBG) over 2–3 months is a strong predictor of HbA_1c (A1C) levels. Glucose instability, the variability of blood glucose levels comprising the MBG, and biological variation in A1C (BV) have also been suggested as predictors of A1C independent of MBG. To assess the relative importance of MBG, BV, and glucose instability on A1C, we analyzed patient data from the Diabetes Control and Complications Trial (DCCT).

RESEARCH DESIGN AND METHODS—A glucose profile set and sample for A1C were collected quarterly over the course of the DCCT from each participant (n = 1,441). The glucose profile set consisted of seven samples, one each drawn before and 90 min after breakfast, lunch, and dinner and one before bedtime. MBG and glucose instability (SD of blood glucose [SDBG]) were calculated as the arithmetic mean and SD of glucose profile set samples for each visit, respectively. A statistical model was developed to predict A1C from MBG, SDBG, and BV, adjusted for diabetes duration, sex, treatment group, stratum, and race.

RESULTS—Data from 32,977 visits were available. The overall model was highly statistically significant (log likelihood = –41,818.75, likelihood ratio ²[7] = 7,218.71, P > ² = 0.0000). MBG and BV had large influences on A1C based on their standardized coefficients. SDBG had only 1/14 of the impact of MBG and 1/10 of the impact of BV.

CONCLUSIONS—MBG and BV have a large influence on A1C, whereas SDBG is relatively unimportant. Consideration of BV as well as MBG in the interpretation of A1C may enhance our ability to monitor diabetes management and predict complications.

Abbreviations: BV, biological variation in HbA_1c • DCCT, Diabetes Control and Complications Trial • HGI, hemoglobin glycation index • MBG, mean blood glucose • SDBG, SD of blood glucose

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E S Kilpatrick Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus J. Clin. Pathol., September 1, 2008; 61(9): 977 - 982. [Abstract] [Full Text] [PDF]

				P. K. Khera, C. H. Joiner, A. Carruthers, C. J. Lindsell, E. P. Smith, R. S. Franco, Y. R. Holmes, and R. M. Cohen Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation Diabetes, September 1, 2008; 57(9): 2445 - 2452. [Abstract] [Full Text] [PDF]

				S. Chalew, J. Hempe, and R. McCarter Comment on: Lachin et al. (2007) The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial: Diabetes 56:1913-1921, 2007 Diabetes, February 1, 2008; 57(2): e4 - e4. [Full Text] [PDF]

				R. M. Cohen A1C: Does One Size Fit All? Diabetes Care, October 1, 2007; 30(10): 2756 - 2758. [Full Text] [PDF]

				E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes Diabetes Care, July 1, 2006; 29(7): 1486 - 1490. [Abstract] [Full Text] [PDF]